| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1101400098 |
| P356 | DOI | 10.1186/S12958-018-0342-1 |
| P932 | PMC publication ID | 5845159 |
| P698 | PubMed publication ID | 29523204 |
| P50 | author | Sandro C. Esteves | Q38325634 |
| Peter Humaidan | Q54217726 | ||
| Thor Haahr | Q57069149 | ||
| P2860 | cites work | Growth hormone for in vitro fertilization | Q24240475 |
| Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice | Q26829747 | ||
| The Bologna criteria for poor ovarian response: a contemporary critical appraisal | Q27021821 | ||
| Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. | Q33587150 | ||
| GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis | Q33770533 | ||
| Twenty years' experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice | Q35558804 | ||
| Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis | Q35994080 | ||
| Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging | Q36057669 | ||
| Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles | Q36293552 | ||
| The science behind 25 years of ovarian stimulation for in vitro fertilization | Q36376695 | ||
| A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology | Q36959947 | ||
| Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles | Q36978308 | ||
| Live-Birth Rate Associated With Repeat In Vitro Fertilization Treatment Cycles | Q37069534 | ||
| Complete in vitro generation of fertile oocytes from mouse primordial germ cells | Q37181818 | ||
| Androgens stimulate early stages of follicular growth in the primate ovary | Q37383118 | ||
| In Vitro Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients | Q37393245 | ||
| The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. | Q37635863 | ||
| Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. | Q37903556 | ||
| A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? | Q37950634 | ||
| The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. | Q37981575 | ||
| Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis | Q38045584 | ||
| Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial | Q38398220 | ||
| The long-term prognosis for live birth in couples initiating fertility treatments | Q38687662 | ||
| Live birth rates in various subgroups of poor ovarian responders fulfilling the Bologna criteria | Q38861972 | ||
| Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology. | Q50494207 | ||
| EGF-like growth factors as mediators of LH action in the ovulatory follicle. | Q50682295 | ||
| Array CGH analysis shows that aneuploidy is not related to the number of embryos generated. | Q51346563 | ||
| Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. | Q52174774 | ||
| Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. | Q52175165 | ||
| Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. | Q52862995 | ||
| Implementing the ESHRE 'poor responder' criteria in research studies: methodological implications | Q56973093 | ||
| The Bologna criteria for poor ovarian response; has the job been accomplished? | Q56981478 | ||
| The definition of 'poor response': Bologna criteria | Q56982793 | ||
| Oogonial Precursor Cell-Derived Autologous Mitochondria Injection to Improve Outcomes in Women With Multiple IVF Failures Due to Low Oocyte Quality: A Clinical Translation | Q39195224 | ||
| Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria | Q39559710 | ||
| Strategies for the management of OHSS: Results from freezing-all cycles | Q39749889 | ||
| ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria | Q39759151 | ||
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | Q40151006 | ||
| Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders | Q40186846 | ||
| Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial | Q40254344 | ||
| Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis | Q42376821 | ||
| In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial | Q44232985 | ||
| Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation | Q44532964 | ||
| Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial | Q46312342 | ||
| Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial | Q46589948 | ||
| Follicular output rate can predict clinical pregnancy in women with unexplained infertility undergoing IVF/ICSI: a prospective cohort study | Q46713731 | ||
| Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles | Q47617444 | ||
| Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation? | Q47658195 | ||
| Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations | Q47856150 | ||
| What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? | Q48003610 | ||
| Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles. | Q48114898 | ||
| Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles | Q48511471 | ||
| A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles | Q48529388 | ||
| Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial | Q48534634 | ||
| Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation | Q48554457 | ||
| A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept | Q48556571 | ||
| The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? | Q48598610 | ||
| Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome | Q48656684 | ||
| Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles | Q48673616 | ||
| Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction | Q48685133 | ||
| Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary | Q48912949 | ||
| Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I. | Q49089999 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | precision medicine | Q17075943 |
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 20 | |
| P577 | publication date | 2018-03-09 | |
| P1433 | published in | Reproductive Biology and Endocrinology | Q15767218 |
| P1476 | title | Individualized controlled ovarian stimulation in expected poor-responders: an update. | |
| P478 | volume | 16 |
| Q64087509 | A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator |
| Q64257251 | An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria |
| Q90680839 | Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection |
| Q91782164 | Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles |
| Q58769667 | Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why |
| Q92132509 | Follicular Output Rate and Follicle-to-Oocyte Index of Low Prognosis Patients According to POSEIDON Criteria: A Retrospective Cohort Study of 32,128 Treatment Cycles |
| Q92238745 | Future Perspectives of POSEIDON Stratification for Clinical Practice and Research |
| Q64257227 | Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification |
| Q91868092 | The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists |
Search more.